MSC–extracellular vesicle microRNAs target host cell-entry receptors in COVID-19: in silico modeling for in vivo validation
We demonstrated that MSCs-EVs are a potential therapeutic option for treating COVID-19 by preventing viral entry into host cells.
Authors
- Omnia A. Badr (ORCID: https://orcid.org/0000-0002-2318-9630)
- Rabab F. Salim (ORCID: https://orcid.org/0000-0003-4139-4678)
- Nicholas R. Forsyth (ORCID: https://orcid.org/0000-0001-5156-4824)
- Mahmoud M. A. Moustafa (ORCID: https://orcid.org/0000-0001-5392-052X)
- Fares E.M. Ali (ORCID: https://orcid.org/0000-0001-8341-7458)
- Mohamed El-Sherbiny (ORCID: https://orcid.org/0000-0002-2689-1409)
- Dalia Shaheen
- Islam Elgohary
- Hajer A Al Saihati
- Nesrine Ebrahim
- Arigue A Dessouky
Institutions
- Alfaisal University (SA)
- Mansoura University (EG)
- Al-Azhar University (EG)
- Zagazig University (EG)
- University of Aberdeen (GB)
- Benha University (EG)
- University of Hafr Al-Batin (SA)
- Almaarefa University
- Keele University (GB)
- Assiut University (EG)
Publication Details
- Journal
- Stem Cell Research & Therapy
- Published
- 2024-09-20
- DOI
- https://doi.org/10.1186/s13287-024-03889-9
- Citations
- 2
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- University of Hafr Al Batin
- AlMaarefa University